Cargando…
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
Autores principales: | Swets, Maaike C, Russell, Clark D, Harrison, Ewen M, Docherty, Annemarie B, Lone, Nazir, Girvan, Michelle, Hardwick, Hayley E, Visser, Leonardus G, Openshaw, Peter J M, Groeneveld, Geert H, Semple, Malcolm G, Baillie, J Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956294/ https://www.ncbi.nlm.nih.gov/pubmed/35344735 http://dx.doi.org/10.1016/S0140-6736(22)00383-X |
Ejemplares similares
-
260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients
por: Swets, Maaike C, et al.
Publicado: (2022) -
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
por: Read, Jonathan M, et al.
Publicado: (2021) -
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
por: Drake, Thomas M, et al.
Publicado: (2021) -
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
por: Swets, Maaike C., et al.
Publicado: (2023) -
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
por: Turtle, Lance, et al.
Publicado: (2023)